Living Donor Kidney Transplantation
7
0
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Proteinuria and Renal Perfusion in Renal Transplant Recipients
Multidisciplinary Support to Access Living Donor Kidney Transplant (MuST AKT)
Multidisciplinary Support To Access Living Donor Kidney Transplant-Pilot
Storytelling to Promote Living Donor Kidney Transplant
TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation
Social Networks and Renal Education: Promoting Transplantation
Adequate Definition of Delayed Graft Function in Living and Deceased Donor Kidney Transplantation